Pages that link to "Q44345826"
Jump to navigation
Jump to search
The following pages link to HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity (Q44345826):
Displaying 50 items.
- Clinical Translation of Nanomedicine. (Q30355939) (← links)
- Water-Soluble, Biocompatible Polyphosphazenes with Controllable and pH-Promoted Degradation Behavior (Q30799901) (← links)
- Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers (Q33235069) (← links)
- Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer (Q33910306) (← links)
- Prodrug applications for targeted cancer therapy (Q34099780) (← links)
- Bioengineering strategies for designing targeted cancer therapies (Q34194191) (← links)
- Polymer-Based Therapeutics (Q34781736) (← links)
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas (Q35130646) (← links)
- Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate (Q35180943) (← links)
- Pro-moieties of antimicrobial peptide prodrugs (Q35543287) (← links)
- Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents. (Q35751371) (← links)
- Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and Alternative (Q35892045) (← links)
- Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium (Q35896698) (← links)
- Polymeric conjugates for drug delivery (Q36029175) (← links)
- Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells (Q36119847) (← links)
- Biological rationale for the design of polymeric anti-cancer nanomedicines (Q36160333) (← links)
- Drug delivery to tumours: recent strategies (Q36301712) (← links)
- Cellular delivery of doxorubicin via pH-controlled hydrazone linkage using multifunctional nano vehicle based on poly(β-l-malic acid) (Q36321843) (← links)
- Polymer architecture and drug delivery (Q36360121) (← links)
- Preparation of chondroitin sulfate-adipic acid dihydrazide-doxorubicin conjugate and its antitumour characteristics against LLC cells (Q36364124) (← links)
- Controlled Multi-functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells (Q36760447) (← links)
- Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy (Q36804366) (← links)
- Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer. (Q36846693) (← links)
- Prodrug strategies in anticancer chemotherapy (Q36982570) (← links)
- In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs. (Q37284600) (← links)
- Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels (Q37307526) (← links)
- Receptor-mediated tumor targeting based on peptide hormones (Q37641368) (← links)
- Acid-degradable polymers for drug delivery: a decade of innovation. (Q38074172) (← links)
- Classification of stimuli-responsive polymers as anticancer drug delivery systems. (Q38189091) (← links)
- Smart chemistry in polymeric nanomedicine. (Q38221776) (← links)
- Selective uptake of cylindrical poly(2-oxazoline) brush-antiDEC205 antibody-OVA antigen conjugates into DEC-positive dendritic cells and subsequent T-cell activation (Q38305108) (← links)
- HPMA Copolymer-Drug Conjugates with Controlled Tumor-Specific Drug Release (Q38626421) (← links)
- Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates. (Q38820373) (← links)
- Novel functionalization strategies to improve drug delivery from polymers. (Q39095290) (← links)
- Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells (Q39144121) (← links)
- Preparation, drug release, and cell growth inhibition of a gelatin: doxorubicin conjugate (Q39149953) (← links)
- Synthesis of maleimide-functionalyzed HPMA-copolymers and in vitro characterization of the aRAGE- and human immunoglobulin (huIgG)-polymer conjugates (Q39226207) (← links)
- Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines (Q39264057) (← links)
- Polypeptide conjugates of d-penicillamine and idarubicin for anticancer therapy (Q39446823) (← links)
- Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma (Q39618387) (← links)
- Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model (Q39778453) (← links)
- PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation (Q39782641) (← links)
- Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma. (Q40649082) (← links)
- Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3). (Q40678981) (← links)
- Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles (Q41957693) (← links)
- Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting (Q44991152) (← links)
- Doxorubicin-loaded polymeric micelles based on amphiphilic polyphosphazenes with poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) and ethyl glycinate as side groups: synthesis, preparation and in vitro evaluation (Q46186804) (← links)
- Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications (Q46408569) (← links)
- Dual-responsive breakdown of nanostructures with high doxorubicin payload for apoptotic anticancer therapy (Q48768819) (← links)
- Supramolecular Drug Delivery Systems Based on Water-Soluble Pillar[n]arenes. (Q51380348) (← links)